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103~ Preserved Basal Raloa=e of Nitric Oxide at 
Spontaneously - Occurring Coronary Spasm Sites 
In PMlents With Variant Angtna 
H, Yamamota, M, Name, H, Orlguehl, 1", l~Jlml, H, Yo~htmurn, KYu~h~ Ko,~et 
Nankln HoPplt~l, Ktt~kyu~ho, Japrln 
~Rckgro~nd: It t~ ~ttll ~nknown whether basal release of nitric oxide (NO) la 
dotlcler~! nt ¢oronary ~pa~m ~ita~. Th~ elm ot tibia study was to Invo~tlgnte 
the ba~¢d ralot~o ol NO nt ~itaa ol ac~lylchellne.l~d~ced coronnq,, spasm 
(ACH.spasm) t~nd ~penlaneo~sty.occL~rrlng coronary apn~m (Spent.spasm). 
whCh I~ mare important pnthophyslologically In patients wllh variant nngle~, 
M~t/~od#: Na-monemethyI.L-nrg nine (L.NMMA ~00 pmol/4 m n), an in. 
hlbitor of NO synth~aa was inlu~od into eoromW arteries in 20 patients 
without ~otvn~w rt,k la¢tam with v~rlanl angina nnd in 10 control p~tiont~, 
GorPn~tq/spaenl wa~ (nd~¢~ort by intr~coronary (nkmlan el ACH (50 .el2 mint 
~n all ~p~aro p~tion(~ The luminal diameter of epicmdinl coronary arteries 
wits i t~es~¢ by q,r~ntltativ~ nngiography, 
R{,~tP3; Baseline coronap/anglogrnms in 0 of 20 opnsm p~tionta showed 
laQitl Bpant.ppoBm (basnllne Coronary dtameler was lass thnn 50% el the di. 
omelet ether ~O~0rbldn dinilmta: ~ponl.BpnBm', 43,6 t 4,5% va ACH.~pasm: 
76.? ~ 5,~%, p - Q,O1), L-NMMA constricted signlt~P, ntly all segmm~tS in 
control p~tt~ntn and both the non-~pa~tlc and ~paatlc ~ites in spasm pn. 
ttanta (% diameter change from baseline: control patients: ~9.3 :t 1,9" and 
~o~.~itsll~ t~ltas: -.8,0 '.~ 2,[i', ? .S  :t: 2,0". spastic silos: 12,5 t 4.6', 
~25,5 :t" B,~*, ACH.spasm nnd Spont.spa,~m, respectively, "P -~ 0,01 vs the 
b~selino), The constrictive mspons~ to L.NMMA at the 8pont-spasm sties 
was grantor than nt tho other sites (p - 0,01). 
Con¢lu,~ton: B~ls~l release el NO exists nt the spasm sites, even when 
coronary spasm I~ occumng spontaneously in patients without coron~lry risk 
t~ctO~,~ wlth variant angina, 
~ Bradyklnln-lnduced Dilation of Coronary 
Resistance Vessels In Patients With 
Hyparcholesterolemla: A Role of Nitric Oxide 
M Kate, N, Shiode, H, Toragawa, T, Yamagata, H, Matsuura, G, Kajiyama, 
F~mt Department of Internal Medicine, Hiroshima University, Hirosh~m,"l, 
Japan 
BaCkgroun¢l: Endotholium-dependont dilations of coronary resistance yes. 
sels mediated by acetylcholine (ACM) are impaired due to depressed trit¢~c 
ox~de tNO) production In hypemhotostorelemic patients, However. it ~S not 
clarified wlleth0r bmdykintn (BK)-induc0d dilation is impeired or not. This 
study was designed to determine whether the ondotheliam-dependont dila. 
tton el coronary resistance vessels mediated by BK is =repaired and whether 
this stgnifiea a depressed NO production in humnn hypercholesterelemla, 
Methods: The coronary vascular responses to ACH and BK were com- 
pared In 12 hyperChelostorotemic and 11 control patients with normal core. 
nary arteries. The responses to BK were repeated after N O-monOmethyI-L-ar- 
ginine infusion in 8 hypercholeatorolemio and 9 control patients. Drug~ were 
inbreed into tr~ taft coronary estium and coronary blood flow (CBF} and 
coronary vascular resistance were calculated by quantitative angiegraphy 
and Doppler flow velocity measurements, 
Resolts: The vasodilator esponse to ACH was reduced in hypercholes- 
terolemic patients (p .. 0.o05). Tl~o response to BK was also reduced m 
hypercholesterelemic patients (p ,: 0.04}, Them wc~s a significant correlation 
between the responses in CBF to ACH and BK (r = 0.56: p - 0.01 ). Howevu,; 
BK-induced dilation was similar between these two groups after NO inhibition. 
Conclusions: Th3so results suggest that endothelium-dependent dilation 
of coronary resistance vessels mediated by ElK is also impaired due to 
depressed NO production in hypercholesterelemia. 
~ Individual and Combined Effects of  Estrogen 
Replacement Therapy and Lovastatln In Women 
With Coronary Disease 
D.M. Herrington, B,L. Werbel, BE. Pusser, T.M. Morgan. Bowman Gray 
School el Medicine Winston.Salem. North Carolina, USA 
6ackground: NCEPII guidelines nuggest estrogen replacement therapy (ERT) 
as an alternative to lipid-lowering drugs in postmenopausal women with core- 
nary adory disease (CAD) and hypedipidemia. But it is unclear if ERT's qpid 
effects equal, exceed, or enhance those of other lipid,lowering drt~gs. 
Methods: Twenty.throe women (moan age 68 yr) with CAD and LDL 
130 mg/dl wore enrolled in a randomized, blinded 3-pedod cross.over teal of 
Promarin 0,625 mg and Provers 2.5 me. Iovastatln 20 me, or bath. Plasma 
liptcc wore massacred at baseline and alter each 6.week treatment period 
Results: Each Individual treatment lowered total cho: ,clare! ~TC) and L[")I=. 
(p ' 0.01). end mlsed HDL (p ~ 0.03). However, ERT + lavastatin lowered 
TC and LDL mot0 than ERT alone (p ..~ 0,001) and raised HBL morn than 
Iovaetaltn alone (p = 0,11). The net affect el comblm~;l therapy on LDL/HDL 
ratio was greater than either treatment alone (p ~ 0.05), Lovastattn also 
blocked the ERT.a¢~octatod increase tn trlgtyca~'ldas (p -~- 0,00t), 
Lipi~ls I~olln~ Lev~t~tin I~RT 0olh 
TC ~49 (5,7) 201 (l~t) ~;~4 (?~) t~ (77) 
LOL I (~,~1 (4,61 1t4 (7.7) 139 (6,~) 1t0 (7,1~) 
HDL 42 (2.0) 47 (2,4] 40 (~,~) 50 l~,3) 
TO 217116,~) t09(2tA) ~37 (20,5) 196{160) 
LOtJHDL 39~ (O tl~) 2:Bl~ (0,2Ol ~94 tO t81 ~',~ (018) 
Conc/o,~ion: Combined ERT plus tcwnst~tin yields morn fsvOf~b!0 plasm~ 
lipid pmlites th~n either treatment alone, 
~ The In•lden©e o1 Caroline Ttroponln I Re!sees 
FOllowing Various Coronary Intervention; A H!ghh/ 
Sensitive Marker to Detect Mi©ro-infarcte 
M,A Knnm. C. Landau, F.W, Menu, E.J. Eic;hhem. Dalla,~ VA Af~d Ctr, UnAv 
el T~xos Soufhtt~stem, Deltas TA', USA 
Cardiac Tropontn I (eTnl), a rogul~teW contractile protein is a unique marker 
of myocardial neeresi~i bocauSo 0t high sensitivity, sp@cificity, and virlually no 
cross reactivity with sketelal tmponln L In Qrder to determine the diagnOstic 
sensitivity of cTnl post.intervention in balloon (BAt, slant (ST), mtablation 
(ROt, and t3CA (DC'), levels were measured to determine the incidence 
ot minor Iniury. as well as to compare its sensitivity with CKMB tettowmg 
the procedure, Pts with acule MI or primary PTCA within 7-t0 days were 
excluded, In 75, Consecutive pts reteTred to the oath lab. c'i'nt [~O.4 noJml), 
CKMB (;-10 lU/1) were measured pre-(eTnl), and 8, 16 (CKMB), and 24 
hrs (cTnl, CKMB) post*coronary tmervention. BA was used as a pnma~ or 
adjunctive device in 74 pts, ST were deployed in 30, Re was used in 13. and 
DC in 6 pie. Five pts worn excluded duo to high pnmary versus secondary 
levels ot cTel. 
Results: Overall. cTnl was elevated in 24 (32%), and CKMB in 8 (10%) 
pts post-PTCA, (p =.  000 1. cTnl vs CKMe). The mean nse of eTnL and 
CKMB was 2,84 ng/ml, and 32.75 IU/I respectively. Fig. t summanzes cTnl 
nee (%) with venous procedures, 
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Conclusions: We conclude that serum eTnl allows a much higher diagnos- 
tic :,'c~racy in detecting minor myocardial injury post-intervention compared 
to CKMB, and that routine measurements of CKME] following PTCA may 
not be useful. Minor cardiac injury is frequent following DCA, common post- 
stenting, and uncommon with mtablation. 
~Does  Bradycardla Promote Coronary Collateral 
Growth in Humans? 
S.R. Patel, J.A. Breall, B,J. Gersh, AP. Levy, Georgetown Univemfly 
Medical Center, Washington. DC, USA 
eackground. The development of mature coronary collaterals in patients 
with obstructive CAD decreases the ischemic burden with a consequent 
impmvemem in symptor.rs systolic function, and a decrease in infest size. 
Chronic bradyeardia has been shown 1o stimulate collateral vessel formation 
in experimental models. We hypothesized that CAD patients with bradycardia 
will demonstrate a better developed collateral circulation compared to a 
control group, 
Methods: Rhythm tracings of cardiac catheterization patients were 
screuned from January to June 1997. All angiograms in patients with heart 
rates ±50 were reviewed. An equivalent number of patients with heart rates 
-65 served as controls. Patients with acute myocardial infarctions, rhythms 
